Browse > Article
http://dx.doi.org/10.5090/kjtcs.2013.46.1.14

Antioxidant Effect of Captopril and Enalapril on Reactive Oxygen Species-Induced Endothelial Dysfunction in the Rabbit Abdominal Aorta  

Kim, Ji Hoon (Department of Medicine, Sicho Subcenter, Seocheon County Public Health Center)
Kim, Hyuck (Department of Thoracic and Cardiovascular Surgery, Hanyang University Seoul Hospital, Hanyang University College of Medicine)
Kim, Young Hak (Department of Thoracic and Cardiovascular Surgery, Hanyang University Seoul Hospital, Hanyang University College of Medicine)
Chung, Won-Sang (Department of Thoracic and Cardiovascular Surgery, Hanyang University Seoul Hospital, Hanyang University College of Medicine)
Suh, Jung Kook (Department of Anesthesiology, Hanyang University Seoul Hospital, Hanyang University College of Medicine)
Kim, Sung Jin (Department of Thoracic and Cardiovascular Surgery, Hanyang University Seoul Hospital, Hanyang University College of Medicine)
Publication Information
Journal of Chest Surgery / v.46, no.1, 2013 , pp. 14-21 More about this Journal
Abstract
Background: Reactive oxygen species (ROS) are known to be related to cardiovascular diseases. Many studies have demonstrated that angiotensin-converting enzyme inhibitors have beneficial effects against ROS. We investigated the antioxidant effect of captopril and enalapril in nitric oxide mediated vascular endothelium-dependent relaxations. Materials and Methods: Isolated rabbit abdominal aorta ring segments were exposed to ROS by electrolysis of the organ bath medium (Krebs-Henseleit solution) after pretreatment with various concentrations (range, $10^{-5}$ to $3{\times}10^{-4}$ M) of captopril and enalapril. Before and after electrolysis, the endothelial function was measured by preconstricting the vessels with norepinephrine ($10^{-6}$ M) followed by the cumulative addition of acetylcholine (range, $3{\times}10^{-8}$ to $10^{-6}$ M). The relevance of the superoxide anion and hydrogen peroxide scavenging effect of captopril and enalapril was investigated using additional pretreatments of diethyldithiocarbamate (DETCA, 0.5 mM), an inhibitor of Cu/Zn superoxide dismutase, and 3-amino-1,2,4-triazole (3AT, 50 mM), an inhibitor of catalase. Results: Both captopril and enalapril preserved vascular endothelium-dependent relaxation after exposure to ROS in a dose-dependent manner (p<0.0001). Pretreatment with DETCA attenuated the antioxidant effect of captopril and enalapril (p<0.0001), but pretreatment with 3AT did not have an effect. Conclusion: Both captopril and enalapril protect endothelium against ROS in a dose-dependent fashion in isolated rabbit abdominal aortas. This protective effect is related to superoxide anion scavenging.
Keywords
Reactive oxygen species; Angiotensin-converting enzyme inhibitors; Captopril; Enalapril; Vasodilation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010;459:923-39.   DOI
2 Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.   DOI
3 Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006;291:H985-1002.   DOI
4 Chen SX, Song T, Zhou SH, Liu YH, Wu SJ, Liu LY. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Eur J Pharmacol 2008;584:368-75.   DOI
5 Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(23 Suppl 1):III27-32.   DOI
6 Bayir H. Reactive oxygen species. Crit Care Med 2005;33(12 Suppl):S498-501.   DOI
7 Gomes A, Costa D, Lima JL, Fernandes E. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem 2006;14:4568-77.   DOI
8 Lazar HL. Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient. Ann Thorac Surg 2005;79:1081-9.   DOI
9 Sun JZ, Cao LH, Liu H. ACE inhibitors in cardiac surgery: current studies and controversies. Hypertens Res 2011;34: 15-22.   DOI
10 Benzie IF, Tomlinson B. Antioxidant power of angiotensin- converting enzyme inhibitors in vitro. Br J Clin Pharmacol 1998;45:168-9.
11 Scribner AW, Loscalzo J, Napoli C. The effect of angiotensin- converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol 2003;482:95-9.   DOI
12 Luscher TF, Boulanger CM, Dohi Y, Yang ZH. Endotheliumderived contracting factors. Hypertension 1992;19:117-30.   DOI
13 Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-6.   DOI
14 Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003;111: 1201-9.   DOI
15 Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009;4: 71-95.   DOI
16 Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 2005;25:1551-7.   DOI
17 Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 2004;11:89-97.   DOI
18 Zhang R, Al-Lamki R, Bai L, et al. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 2004;94:1483-91.   DOI
19 Jackson CV, Mickelson JK, Stringer K, Rao PS, Lucchesi BR. Electrolysis-induced myocardial dysfunction: a novel method for the study of free radical mediated tissue injury. J Pharmacol Methods 1986;15:305-20.   DOI
20 Peters SL, Mathy MJ, Pfaffendorf M, van Zwieten PA. Reactive oxygen species-induced aortic vasoconstriction and deterioration of functional integrity. Naunyn Schmiedebergs Arch Pharmacol 2000;361:127-33.   DOI
21 Margoliash E, Novogrodsky A. A study of the inhibition of catalase by 3-amino-1:2:4:-triazole. Biochem J 1958;68: 468-75.   DOI
22 de Groot AA, Mathy MJ, van Zwieten PA, Peters SL. Antioxidant activity of nebivolol in the rat aorta. J Cardiovasc Pharmacol 2004;43:148-53.   DOI
23 Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-der ived relaxing factor. J Pharmacol Exp Ther 1991;257:1136-45.
24 Wambi-Kiesse CO, Katusic ZS. Inhibition of copper/zinc superoxide dismutase impairs NO.-mediated endothelium-dependent relaxations. Am J Physiol 1999;276(3 Pt 2):H1043-8.
25 Chopra M, Scott N, McMurray J, et al. Captopril: a free radical scavenger. Br J Clin Pharmacol 1989;27:396-9.   DOI
26 Mittra S, Singh M. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Mol Cell Biochem 1998;183:63-7.   DOI
27 Pi XJ, Chen X. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts. J Mol Cell Cardiol 1989;21:1261-71.   DOI
28 Fujita N, Manabe H, Yoshida N, et al. Inhibition of angiotensin- converting enzyme protects endothelial cell against hypoxia/ reoxygenation injury. Biofactors 2000;11:257-66.   DOI
29 Fernandes E, Costa D, Toste SA, Lima JL, Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 2004;37: 1895-905.   DOI
30 Duchene J, Ahluwalia A. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease. Curr Opin Pharmacol 2009;9:125-31.   DOI